FDA Inspection 1256100 — University Of CA Irvine Medical Center Blood Bank
The FDA completed an inspection of University Of CA Irvine Medical Center Blood Bank on Nov 22, 2024 in Orange, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Orange, CA (United States)